RULE 19.6(c) CONFIRMATION WITH RESPECT TO STATED POST-OFFER INTENTIONS WITH REGARD TO HVIVO PLC
Open Orphan PLC (ORPH.L) Rule 19.6(c) Confirmation
Omega Diagnostics Gp (ODX.L) Update re AbC-19 Rapid Test
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, notes today’s update from Abingdon Health plc (AIM: ABDX)
UK to roll out Oxford COVID-19 vaccine from Jan. 4, Sunday Telegraph
LONDON (Reuters) – The United Kingdom will roll out Oxford University’s COVID-19 vaccine from Jan. 4, according to plans being drawn up by ministers, The Sunday Telegraph reported.
Omega Diagnostics Group PLC (ODX.L) Mologic CE Mark Rapid Antigen Test
Omega (AIM: ODX), the medical diagnostics company focused on CD4, infectious diseases and food intolerance, welcomes the news that Mologic Ltd (“Mologic”) has received CE Mark for it’s professional-use COVID-19
Remote Monitored Systems (RMS.L) Update on Fundraising and response to announcements from Dr. Cave
The board of directors of Remote Monitored Systems plc (“Board”), is pleased to provide the following update in respect of the placing raising gross proceeds of £5m announced on 18
Open Orphan PLC (ORPH.L) Successful completion of toxicology study
Successful completion of PrEP Biopharm Toxicology study for respiratory ‘viral mimic’
Dr Hugo Stephenson, CEO of Induction Healthcare Group PLC (INHC.L) Interview
Dr Hugo Stephenson, Joint-CEO of Induction Healthcare, said: The Group has generated excellent commercial momentum in the first half of the current financial year and has delivered its first full
Open Orphan PLC (ORPH.L) Contract renewal with top-3 pharmaceutical client
Successful extension of contract underpins 2021 revenue growth expectations
Substantial RMS Shareholder Support for Dr Cave, Remote Monitored Systems PLC
Private Investor support for Dr Cave’s plan to vote against warrants and in favour of board changes to improve corporate governance now exceeds his own 17.7% shareholding
Genedrive PLC (GDR.L) 96 SARS CoV-2 Kit able to detect all published virus strains
Genedrive plc (AIM: GDR), the near-patient molecular diagnostics company, confirms that its Genedrive 96 SARS CoV-2 Kit continues to detect all known variants of COVID-19, including the newest variants released
Remote Monitored Sys (RMS.L) Placing to raise £5,000,000 and Issue of Warrants
Remote Monitored Systems PLC is pleased to announce that the Company has conditionally raised gross proceeds of £5,000,000 through an oversubscribed placing of 400,000,000 new ordinary shares (the “Placing Shares”)
